Preclinical Evaluation of a Novel Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold in Porcine Coronary Artery at 6 Months
JACC. Cardiovascular interventions | 9 Feb 2019
JF Zheng, H Qiu, Y Tian, XY Hu, T Luo, C Wu, Y Tian, Y Tang, LF Song, L Li, L Xu, B Xu and RL Gao
The aim of this study was to investigate the operability, 6-month efficacy, and safety of the novel sirolimus-eluting iron bioresorbable coronary scaffold (IBS) system compared with a cobalt-chromium everolimus-eluting stent (EES) (XIENCE Prime stent) in porcine coronary arteries.
* Data courtesy of Altmetric.com